Jana Jarolimova1,2,3, Laura R Platt1,2,3, Megan R Curtis2,3, Lisa L Philpotts4, Linda-Gail Bekker5, Chelsea Morroni6,7,8,9, Maryam Shahmanesh10,11, Aamirah Mussa8, Khallela Barracks12, Andrea L Ciaranello1,2,3, Robert A Parker3,13,14, Ingrid V Bassett1,2,3,14, Caitlin M Dugdale1,2,3. 1. Medical Practice Evaluation Center. 2. Division of Infectious Diseases, Massachusetts General Hospital. 3. Harvard Medical School. 4. Treadwell Library, Massachusetts General Hospital, Boston, Massachusetts, USA. 5. The Desmond Tutu HIV Centre. 6. School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa. 7. MRC Center for Reproductive Health, University of Edinburgh, UK. 8. Botswana Harvard AIDS Institute Partnership. 9. Botswana Sexual and Reproductive Health Initiative, Gaborone, Botswana. 10. Africa Health Research Institute, Durban, South Africa. 11. Institute for Global Health, University College of London, London, UK. 12. Barnard College, New York, New York. 13. Biostatistics Center, Massachusetts General Hospital. 14. Center for AIDS Research, Harvard University, Boston, Massachusetts, USA.
Abstract
OBJECTIVES: Sexually transmitted infections (STIs) cause significant morbidity among women with HIV and increase HIV transmission. We estimated the prevalence of four STIs among women with HIV in sub-Saharan Africa (SSA) and compared prevalence among women with and without HIV. DESIGN: Systematic review and meta-analysis. METHODS: We searched for studies published 1 January 1999 to 19 December 2019 reporting prevalence of gonorrhea, chlamydia, trichomoniasis, or Mycoplasma genitalium among women with HIV in SSA. We excluded studies conducted in high-risk groups (e.g. female sex workers). We extracted data on laboratory-confirmed STIs among women with HIV, and when included, among women without HIV. We estimated pooled prevalence for each STI among women with HIV using inverse variance heterogeneity meta-analysis, compared prevalence to women without HIV, and examined the influences of region, clinical setting, and pregnancy status in subgroup analyses. RESULTS: We identified 3756 unique records; 67 studies were included in the meta-analysis. Prevalence of gonorrhea, chlamydia, trichomoniasis, and M. genitalium was 3.5, 4, 15.6, and 10.2%, respectively. Chlamydia prevalence was lower in Eastern (2.8%) than in Southern (12.5%) and West/Central (19.1%) Africa combined. Prevalence of chlamydia and trichomoniasis was higher among pregnant (8.1%, 17.6%) than nonpregnant (1.7%, 12.3%) women. All STIs were more prevalent among women with than without HIV (relative risks ranging 1.54-1.89). CONCLUSION: STIs are common among women with HIV in SSA, and more common among women with than without HIV. Integrated STI and HIV care could substantially impact STI burden among women with HIV, with potential downstream impacts on HIV transmission.
OBJECTIVES: Sexually transmitted infections (STIs) cause significant morbidity among women with HIV and increase HIV transmission. We estimated the prevalence of four STIs among women with HIV in sub-Saharan Africa (SSA) and compared prevalence among women with and without HIV. DESIGN: Systematic review and meta-analysis. METHODS: We searched for studies published 1 January 1999 to 19 December 2019 reporting prevalence of gonorrhea, chlamydia, trichomoniasis, or Mycoplasma genitalium among women with HIV in SSA. We excluded studies conducted in high-risk groups (e.g. female sex workers). We extracted data on laboratory-confirmed STIs among women with HIV, and when included, among women without HIV. We estimated pooled prevalence for each STI among women with HIV using inverse variance heterogeneity meta-analysis, compared prevalence to women without HIV, and examined the influences of region, clinical setting, and pregnancy status in subgroup analyses. RESULTS: We identified 3756 unique records; 67 studies were included in the meta-analysis. Prevalence of gonorrhea, chlamydia, trichomoniasis, and M. genitalium was 3.5, 4, 15.6, and 10.2%, respectively. Chlamydia prevalence was lower in Eastern (2.8%) than in Southern (12.5%) and West/Central (19.1%) Africa combined. Prevalence of chlamydia and trichomoniasis was higher among pregnant (8.1%, 17.6%) than nonpregnant (1.7%, 12.3%) women. All STIs were more prevalent among women with than without HIV (relative risks ranging 1.54-1.89). CONCLUSION: STIs are common among women with HIV in SSA, and more common among women with than without HIV. Integrated STI and HIV care could substantially impact STI burden among women with HIV, with potential downstream impacts on HIV transmission.
Authors: Eline L Korenromp; Mondastri K Sudaryo; Sake J de Vlas; Ronald H Gray; Nelson K Sewankambo; David Serwadda; Maria J Wawer; J Dik F Habbema Journal: Int J STD AIDS Date: 2002-02 Impact factor: 1.359
Authors: W Fawzi; G Msamanga; B Renjifo; D Spiegelman; E Urassa; L Hashemi; G Antelman; M Essex; D Hunter Journal: AIDS Date: 2001-06-15 Impact factor: 4.177
Authors: Christel Chehoud; Daniel J Stieh; Aubrey G Bailey; Alice L Laughlin; Shannon A Allen; Kerrie L McCotter; Scott A Sherrill-Mix; Thomas J Hope; Frederic D Bushman Journal: AIDS Date: 2017-04-24 Impact factor: 4.177
Authors: Koleka Mlisana; Nivashnee Naicker; Lise Werner; Lindi Roberts; Francois van Loggerenberg; Cheryl Baxter; Jo-Ann S Passmore; Anneke C Grobler; A Willem Sturm; Carolyn Williamson; Katharina Ronacher; Gerhard Walzl; Salim S Abdool Karim Journal: J Infect Dis Date: 2012-04-19 Impact factor: 5.226
Authors: Kristina Adachi; Jiahong Xu; Nava Yeganeh; Margaret Camarca; Mariza G Morgado; D Heather Watts; Lynne M Mofenson; Valdilea G Veloso; Jose Henrique Pilotto; Esau Joao; Glenda Gray; Gerhard Theron; Breno Santos; Rosana Fonseca; Regis Kreitchmann; Jorge Pinto; Marisa M Mussi-Pinhata; Mariana Ceriotto; Daisy Maria Machado; Yvonne J Bryson; Beatriz Grinsztejn; Jack Moye; Jeffrey D Klausner; Claire C Bristow; Ruth Dickover; Mark Mirochnick; Karin Nielsen-Saines Journal: PLoS One Date: 2018-01-05 Impact factor: 3.240